Industry

DUBLIN–(BUSINESS WIRE)–The “Continuous Glucose Monitoring Systems Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Continuous Glucose Monitoring Systems Market is projected to reach USD 8,794.97 million by 2027 from USD 4,432.35 million in 2021, at a CAGR 12.09% during the forecast period. In this report, the … [Read more…]

AUSTIN, Texas–(BUSINESS WIRE)–DisperSol Technologies, LLC, a specialty pharmaceutical company, today announced the appointment of Tim Scott as president and chief executive officer (CEO) of the company. At the same time, the company announced that it is changing its name to AustinPx™, Pharmaceutics and Manufacturing, to better reflect the company’s new direction as a contract development … [Read more…]

Data support request for Emergency Use Authorization of a 30-µg booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12 years of age and older Companies have rapidly scaled production and stand ready to deliver doses of Omicron BA.4/BA.5-adapted bivalent vaccines for September, and will begin shipping immediately pending authorization Rolling submission for … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Breast Cancer Liquid Biopsy Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The breast cancer liquid biopsy market is poised to grow by $464.12 mn during 2022-2026, accelerating at a CAGR of 16.35% during the forecast period. The report on the breast cancer liquid biopsy market provides a holistic analysis, market … [Read more…]

Indonesia National Agency for Drug and Food Control, BPOM, Approved QDENGA (TAK-003) for Use in Individuals Six Years to 45 Years of Age1 QDENGA is the Only Dengue Vaccine Approved in Indonesia for Use in Individuals Without Need for Pre-vaccination Testing Indonesia Approval Marks the First for QDENGA, Takeda’s First Marketed Vaccine Outside of Japan … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Neonatal Intensive Care Respiratory Devices Market Research Report by Device Type, End-User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Neonatal Intensive Care Respiratory Devices Market size was estimated at USD 1,686.97 million in 2021, USD 1,910.92 million in 2022, and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “North America Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type, Product Type, End User, Organization Size, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The North American pharmaceutical analytical testing outsourcing market is projected to grow by 7.5% annually in the forecast period and reach $ … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–#CardiacAblation—Thermedical®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today that the U.S. Food & Drug Administration (FDA) has approved an open-label, single-arm interventional clinical trial to evaluate the safety and efficacy of the Thermedical® SERF Ablation System with the Durablate® Catheter in people with ventricular tachycardia (VT) resistant to conventional … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Europe Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type, Product Type, End User, Organization Size, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The European pharmaceutical analytical testing outsourcing market was valued at $1,919.1 million in 2021 and will grow by 8.4% annually over 2021-2031, driven … [Read more…]

VANCOUVER, British Columbia–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative disorders, today announced positive results from a bioequivalence study with ALPHA-1062, a proprietary, delayed release oral tablet formulation in development for the treatment of mild to moderate … [Read more…]